Up next

Autoplay

Using Blinatumomab in Acute Lymphoblastic Leukemia

0 Views • 06/15/23
Share
Embed
administrator
administrator
Subscribers
0

The discussants, Bijal D. Shah, MD, and Raoul Tibes, MD, PhD, elaborate on the administration and safety of bi-specific T-cell engager, blinatumomab, in the treatment of acute lymphoblastic leukemia.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay